Home » Newsletters » BioWorld Asia

BioWorld Asia

March 29, 2000

View Archived Issues

Actelion Files For 1M-share IPO On Swiss New Market

Axxima completes DM20 Million Financing For Anti-Infectives

Researchers Find Hippocampi Area Of Adult Brain Can Grow

Matrix begins DO2 trial

European Court Deals Another Blow To Clarity On Biotech

Toronto Researchers Discover Gene Regulating Cancer Growth

Survey shows European skepticism over GM foods grows

Israeli Biotechnology Seen As Opportunity Not To Be Missed

Promise Of Gains In Genetic Research Raises Firm's Shares

Despite Market Falloff, Transghne Still Plans To Carry Out Offering

Peptide Therapeutics To Sell Its Drug Discovery Unit To Medivir

Scotia Talking With Possible Partners On Foscan PDT

Eurogen Moving Collar Device For Gene Delivery Into Phase I

Other News To Note

Sweden's Karo Bio In Agreement To Buy Novalon, U.S. Biotech Firm

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...